George Kokotos

Athens, ESYE31 15771, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

A Sustainable Visible Light-Mediated Synthesis of Benzoxazole 2-Carboxylates/Carboxamides.

A Sustainable Visible Light-Mediated Synthesis of Benzoxazole 2-Carboxylates/Carboxamides.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: September 20, 2025

Thiazolyl 4-carboxylate ketone as a new warhead for a highly potent SARS-CoV-2 main protease inhibitor.

Thiazolyl 4-carboxylate ketone as a new warhead for a highly potent SARS-CoV-2 main protease inhibitor.

Journal: European journal of medicinal chemistry

Published: August 28, 2025

Specificity mechanism of Group VIA calcium-independent phospholipase A2 toward truncated-oxidized phospholipids and its application for specific inhibitor design.

Specificity mechanism of Group VIA calcium-independent phospholipase A2 toward truncated-oxidized phospholipids and its application for specific inhibitor design.

Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids

Published: March 21, 2025

A Lipidomic Approach to Studying the Downregulation of Free Fatty Acids by Cytosolic Phospholipase A2 Inhibitors.

A Lipidomic Approach to Studying the Downregulation of Free Fatty Acids by Cytosolic Phospholipase A2 Inhibitors.

Journal: Biomolecules

Published: February 10, 2025

FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinoma.

FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinoma.

Journal: Cancer & metabolism

Published: December 04, 2024

Construction of a Library of Fatty Acid Esters of Hydroxy Fatty Acids.

Construction of a Library of Fatty Acid Esters of Hydroxy Fatty Acids.

Journal: Molecules (Basel, Switzerland)

Published: November 27, 2024

Histone Deacetylase (HDAC) Inhibitors as a Novel Therapeutic Option Against Fibrotic and Inflammatory Diseases.

Histone Deacetylase (HDAC) Inhibitors as a Novel Therapeutic Option Against Fibrotic and Inflammatory Diseases.

Journal: Biomolecules

Published: November 09, 2024

Electron Donor-Acceptor Complex-Assisted Photochemical Conversion of O-2-Nitrobenzyl Protected Hydroxamates to Amides.

Electron Donor-Acceptor Complex-Assisted Photochemical Conversion of O-2-Nitrobenzyl Protected Hydroxamates to Amides.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: August 08, 2024

Computational and Spectroscopic Studies on the Formation of Halogen-Bonded Complexes Between Tertiary Amines and CBr4 and Application in the Light-Mediated Amino Acid Coupling.

Computational and Spectroscopic Studies on the Formation of Halogen-Bonded Complexes Between Tertiary Amines and CBr4 and Application in the Light-Mediated Amino Acid Coupling.

Journal: ChemPlusChem

Published: February 12, 2024

Asymmetric Synthesis of Saturated and Unsaturated Hydroxy Fatty Acids (HFAs) and Study of Their Antiproliferative Activity.

Asymmetric Synthesis of Saturated and Unsaturated Hydroxy Fatty Acids (HFAs) and Study of Their Antiproliferative Activity.

Journal: Biomolecules

Published: December 06, 2023

Next generation thiazolyl ketone inhibitors of cytosolic phospholipase A2 α for targeted cancer therapy.

Next generation thiazolyl ketone inhibitors of cytosolic phospholipase A2 α for targeted cancer therapy.

Journal: Nature communications

Published: October 24, 2023

N-(2-Aminophenyl)-benzamide Inhibitors of Class I HDAC Enzymes with Antiproliferative and Antifibrotic Activity.

N-(2-Aminophenyl)-benzamide Inhibitors of Class I HDAC Enzymes with Antiproliferative and Antifibrotic Activity.

Journal: Journal of medicinal chemistry

Published: October 05, 2023

Showing 1-12 of 71

Last Updated: 09/26/2026